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Abstract
Background: Competing causes of mortality in the elderly decrease the potential net benefit from colorectal
cancer screening and increase the likelihood of potential harms. Individualized decision making has been
recommended, so that the elderly can decide whether or not to undergo colorectal cancer (CRC) screening. The
objective is to develop and test a decision aid designed to promote individualized colorectal cancer screening
decision making for adults age 75 and over.
Methods: We used formative research and cognitive testing to develop and refine the decision aid. We then
tested the decision aid in an uncontrolled trial. The primary outcome was the proportion of patients who were
prepared to make an individualized decision, defined a priori as having adequate knowledge (10/15 questions
correct) and clear values (25 or less on values clarity subscale of decisional conflict scale). Secondary outcomes
included overall score on the decisional conflict scale, and preferences for undergoing screening.
Results: We enrolled 46 adults in the trial. The decision aid increased the proportion of participants with adequate
knowledge from 4% to 52% (p < 0.01) and the proportion prepared to make an individualized decision from 4% to
41% (p < 0.01). The proportion that preferred to undergo CRC screening decreased from 67% to 61% (p = 0. 76); 7
participants (15%) changed screening preference (5 against screening, 2 in favor of screening)
Conclusion: In an uncontrolled trial, the elderly participants appeared better prepared to make an individualized
decision about whether or not to undergo CRC screening after using the decision aid.
Background
Colorectal cancer (CRC) screening is effective in
decreasing disease-specific mortality in adults 50- 75
[1-3] but evidence about the effectiveness of CRC
screening is limited for adults age 75 and older [4-7].
Extrapolating from trials in younger populations, it
appears that factors, such as age and health status (and
their effects on life expectancy) are important for deter-
mining whether older individuals could realize net bene-
f i tf r o mC R Cs c r e e n i n g .T h eU . S .P r e v e n t i v eS e r v i c e s
Task Force recommended in 2008 that persons aged 75
years and older not undergo routine CRC screening,
indicating that the potential to benefit from screening
should be considered at an individual level [8]. Similarly
other expert groups, including the American Cancer
Society, and the American Geriatrics Society, recom-
mend that decisions about whether or not to undergo
cancer screening in older adults are individualized based
on the expectation of benefit, burden and potential
harms of screening, and patient preference [9,10]. Taken
together, guidelines suggest that decision making about
whether or not to undergo CRC screening be individua-
lized based on both: 1) consideration of the patients’
health status and likely longevity; and 2) patient prefer-
ences about screening once they are informed about the
potential benefits and harms.
Despite these recommendations evidence suggests that
decision making for CRC screening in older adults
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any medium, provided the original work is properly cited.could be improved [11]. Ideally, individualized decision
making would promote screening in those who are
healthy and most likely to benefit, discourage screening
in those with multiple co-morbid conditions who are
most likely to be harmed from screening, and educate
patients so that their preferences about whether or not
to undergo screening are informed [6]. However, obser-
vational data indicate no consistent association between
screening test completion and health status [11-15].
Furthermore, older adults may be inadequately informed
about the potential benefits and harms of cancer screen-
ing [16,17], and the elderly may not understand the
effect of competing causes of mortality on the net bene-
fit from undergoing screening [18]. Effective interven-
tions to assure that patients are appropriately informed
and have considered their personal preferences during
colorectal cancer screening decision making are needed
to ensure patients receive high-quality, guideline-con-
cordant care.
One potential method for improving decision making
is through the use of patient decision aids. In rando-
mized controlled trials, use of decision aids compared to
usual care has been shown to increase knowledge,
decrease decisional conflict, reduce the proportion of
people who are undecided, and increase the proportion
who participate actively in decision making [19]. How-
ever, to our knowledge only one decision aid has been
designed to promote individualized decision making in
older people, that being for mammography in older
women [20].
Effective decision aids have been developed and tested
to assist colorectal cancer screening decisions in middle-
aged adults [21,22]. These decision aids addressed deci-
sions regarding CRC screening test choice. They did not
target older adults for whom the decision of whether to
undergo screening rests on how likely screening is to
benefit an individual. Efforts to educate older adults
about the efficacy of screening have been successful in
increasing knowledge in adults age 65 and older [23-25],
however, these studies were limited because the educa-
tional information provided did not consider health sta-
tus. Additionally, neither study explicitly addressed
patients’ preferences by assessing their feelings about
specific attributes of the screening decision.
To begin to address these gaps in the existing
research, we sought to develop a targeted decision aid
for adults age 75 and older designed to promote indivi-
dualized decision making. Our goals for this study were
to develop an acceptable, understandable decision aid
and determine whether the decision aid could prepare
older adults for individualized decision making. We first
describe the steps we took to develop and formatively
test and refine the content of the decision aid. Then, we
report the results of an uncontrolled trial on several
decision making outcomes among participants age 75
and older who used the decision aid. Because individua-
lized decision making outcomes and processes could be
influenced by participant characteristics, we also con-
ducted exploratory analysis to assess whether these deci-
sion making outcomes were associated with participant
characteristics, such as literacy, patient demographics,
and health state.
Methods
The study was conducted in two phases, a developmen-
tal stage and a testing stage. For the developmental
phase we evaluated the decision aid content using cog-
nitive interviewing techniques. For the testing phase we
determined the effect of the decision aid on several deci-
sion making outcomes, using a pre-post test design.
Development Phase
Recruitment and Eligibility
For the development phase, we recruited a convenience
sample of participants from a local senior center. Older
adults were eligible if they were age 75 and older and
could read and speak English. We used two methods to
recruit participants. We approached seniors at the cen-
ter in person and invited them to participate. If they
agreed and were eligible, the senior center provided a
private room in which the participants and the research
assistant could interact. In addition, we contacted elders
who were participating in a pharmacist program of
medication management. These elders qualified for the
medication management program if they were home-
bound and on multiple medications. During one of her
visits to the homes of elders participating in the medical
management program, the pharmacist asked for their
permission for us to contact them. If permission was
granted, the pharmacist provided contact information to
our research assistant who called potential participants
at their homes. If they chose to participate, our research
assistant (RA) arranged an appointment with them
either in their home or at the senior center. For this
phase of the study, there were 15 participants who were
interviewed.
Decision Aid Development
We based the content of the decision aid on several
conceptual frameworks. Walter and Convinsky pro-
prosed a framework of individualized decision making
for elders facing cancer screening decisions [6]. They
proposed that the decision about cancer screening in
the elderly depends on an assessment of the potential
net benefit from undergoing screening and patient pre-
ference. Underlying this individualized decision making
framework for the elderly is the more general concept
of informed decision making. For people to make an
informed decision they must be aware of the risk,
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medical decision [26-28] to develop tools to assist
patients so that they can make informed medical deci-
sions consistent with their personal values. Based on the
Ottawa framework and internal standards for decision
aid development [29] we developed two components for
the decision aid, an educational component and a values
clarification component.
Educational Content
In the first phase, we developed and tested key messages
which would facilitate individualized decision making
for elders. From the existing literature, we identified
information about the risks of CRC compared to other
common causes of death in older adults (stroke and cor-
onary heart disease) and information about the potential
benefits of CRC in the general population, as age speci-
fic information was not available at the time. From in-
depth interviews with adults age 75 and older [18] we
identified a lack of knowledge about both the delayed
benefit from screening and the need to make an indivi-
dualized decision about CRC screening. From these
data, we developed 5 key messages for formative testing:
1) There is a lack of direct research evidence support-
ing screening for those ages 75 and older; therefore, The
American Cancer Society recommends that adults age
75 and older decide whether or not to get screened for
colon cancer.
2) The risk of dying from CRC increases with age.
3) The risk of dying from of other common diseases
also increases with age.
4) The importance of considering competing causes of
mortality when determining whether CRC could be ben-
eficial for older adults.
5) Colon cancer is relatively slow growing; people
must be expected to live 5 to 10 years to have their life
saved from colon cancer screening.
Using these messages, we performed the first round of
cognitive interviews to refine the content of the elder-
specific-decision aid messages. We tested whether parti-
cipants: 1) could understand the information in each
message; 2) found the information acceptable (and not
offensive), and 3) thought the information was impor-
tant to their decision about colorectal cancer screening.
The messages were modified in an iterative fashion and
cognitive interviews were continued until we reached
saturation, that is we were not obtaining additional feed-
back. We completed a total of 15 cognitive interviews at
this stage of development. The general concepts of the
decision aid were understood by participants, thought to
be important to decisions about CRC screening, and not
found to be offensive to respondents.
With these messages as the core content, we then
developed a paper version of the decision aid. The five
key messages were incorporated into the paper based
decision aid explaining why individualized decision mak-
ing is important (Table 1). In addition to this section, we
developed an introductory page outlining who should use
this decision aid; a section of educational information
briefly describing two screening tests (colonoscopy and
fecal occult blood testing). In this section we explained
that although fecal occult blood testing was an option, if
the cards were positive, then colonoscopy would be
needed to rule out the possibility of CRC. Consequently,
the decision about whether or not to undergo CRC
screening should be made by considering of the risks and
benefits of colonoscopy. We also included a brief descrip-
tion of treatment options if CRC is found. We developed
graphics demonstrating risk information including the
potential benefits of CRC screening, risks of having ser-
ious complications from colonoscopy (bleeding, perfora-
tion, and death); and graphics demonstrating the balance
of the risks and benefits for people in good, fair, and poor
health states. Information about the risk of dying from
CRC compared to stroke and heart disease was targeted
to the participants’ age and gender. The targeted infor-
mation was presented in 5 year age increments 75 to 79,
80 to 84, and 85 to 90. Stroke and heart disease were
chosen because they are leading causes of mortality in
the elderly. This information was based on risks reported
by Schwartz and colleagues describing competing causes
of mortality [30].
Values Clarification Content
As we developed and tested the educational component
of the paper-based decision aid, we also developed and
tested the content and process for a values clarification
exercise. As there is no standard values clarification pro-
cess, we based our process on an exercise developed for
a prostate cancer screening decision aid by one of our
co-authors. (Golin, CE, personal communication, April
2007). Our goal was to have a process that reflected the
participants summed responses to the statements, so
that participants could compare the results of the score
from the values clarification exercise in the decision aid
with their stated screening preference. We identified
nine constructs related to decisions about colorectal
cancer screening in older adults that could vary depend-
ing on older adults’ values and could be important as
they make decisions about cancer screening (Table 2).
These constructs were identified as important for deci-
sion making during interviews with older adults [18].
Two cards were developed for each construct: one in
favor of screening and one not. The participants
reviewed the nine pairs of color-coded cards one at a
time, and for each pair, chose which card best repre-
sented how they felt about that screening-related con-
struct. The blue-colored cards supported screening,
while the yellow colored cards were against further
screening. Each choice was scored as +1 in favor of
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choices was used to generate a score from -9 (nine
choices against screening) to +9 (nine choices in favor
of screening). At the end of the exercise the RA sum-
marized the number of cards in favor (blue) and the
number against (yellow). For example, “It looks like
you’ve selected 7 blue cards and 2 yellow cards. The
blue cards represent statements you might say if colon
cancer screening was something you would want to do.
The yellow cards represent statements you might say if
colon cancer screening was something you weren’t
interested in doing. Since you selected more blue than
yellow cards it looks like you are leaning towards colon
cancer screening. Would you agree with that?” If they
did not agree, the participant was encouraged to explain
why they did not.
Final Content of the Decision Aid
We performed another round of cognitive testing
using the complete decision aid which included the
informational component and the values clarification
exercise. For this round of testing, the participants
read each page of the decision aid and reflected back
their understanding and impressions of the content.
For each page, we evaluated the text, layout, graphics,
and figures (Figures 1, 2, and 3). They also completed
the values clarification exercise and provided verbal
feedback to the RA about the process and the content.
The process was iterative. We completed seven cogni-
tive interviews testing the complete decision aid. Few
changes were necessary. Some wording was changed
to enhance understanding. The only substantive feed-
back was that the participants wanted us to better
clarify that the outcomes from the risk tables were
averages, and on an individual level, it is impossible to
know who will benefit from screening. The final con-
tent of the educational component is available at
http://www.shareddecisionmaking.org/Site/Female%
20Age%2080.pdf.
Table 1 Summary of the Educational Content of the Decision Aid by Section.
Title of Section Summary of content
Introduction ￿ American Cancer Society (ACS) recommends individualized decision making for older
adults age 75 and over.
￿ This decision aid will help you think about whether colorectal cancer screening is the
right choice for you.
Information about Colon Cancer Screening ￿ Colorectal cancer screening tests look for colon cancer before you have symptoms.
Two Main Types of Tests that Screen for Colon Cancer ￿ Colonoscopy is a procedure that requires preparation and occurs at the doctor’s office.
￿ Stool cards can be done at home and returned to the doctor’s office.
Those with cards positive for blood will need to have a colonoscopy.
Treatments People Undergo if Colon Cancer is Found ￿ Most people with invasive colon cancer will need surgery.
￿ Some people may need chemotherapy after surgery.
Colon Cancer Screening Recommendations Are
Different for Older Adults
￿ As adults get older they are more likely to encounter numerous health problems that
could affect their life expectancy.
￿ We are not sure whether screening is beneficial for those 75 years and older.
￿ That is why the ACS recommends older adults decide about colorectal cancer screening
for themselves.
Why do Older Adults Need to Decide for Themselves
about Colon Cancer Screening?
￿ The chances of getting a serious illness go up with increased age. Older adults are also
more likely to develop colon cancer.
Life expectancies for older adults vary with the number of serious health problems.
￿ In most cases colon cancer grows slowly. If someone develops colon cancer today he
may not have any problems for 5-10 years.
￿ Colon cancer screening will not help all older people. A person’s life expectancy can be
influenced by their current health condition.
￿ Older adults must deal with competing causes of death. Other health problems may lead
to death before colon cancer.
￿ There is uncertainty about who will benefit. No one can know how long any individual
will live.
Magnitude of potential benefit from colon cancer
screening
￿ One life is extended for every 1000 people who are screened.
Risks to Consider in Making Your Decision about Colon
Cancer Screening
￿ Pictograph (Figure 1) compares the risk of dying from heart disease, stroke or colon
cancer over 10 years.
￿ Pictograph (Figure 2) compares the risk of having a complication (bleeding, perforation
or death) after the first 30 days of a colonoscopy.
Balancing the Benefits and Risks of Colonoscopy in
People age 75 and Older
￿ Figure 3 compares how a person’s health can influence the balance between the
benefits and risks of colon cancer screening.
The table is divided into 2 columns. The first column lists the title of each section in the decision aid. The second column is a summary of the content in each
section. Full content is available at http://www.shareddecisionmaking.org/Site/Female%20Age%2080.pdf
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Recruitment and Eligibility
We recruited patients for the uncontrolled trial using
the same methods described above. We recruited only
those who had not participated in the formative testing.
For the uncontrolled trial additional measures were
obtained. The RA administered the Short Test of Func-
tional Health Literacy in Adults [31], the Four Year
Mortality Index [32], and a check list of medical condi-
tions based on the Charlson Co-morbidity Index [33].
To exclude older adults with life expectancies of less
than two years who would be unlikely benefit from
screening, we planned to exclude people who reported
end stage renal disease on dialysis, all oxygen dependent
conditions, severe congestive heart failure, or terminal
cancer but none that we recruited had these severe con-
ditions. We also excluded people with a self-reported
history of colon cancer. We screened potential partici-
pants for dementia using the Callahan’s six item screen,
a validated instrument[34], and excluded those with
positive results.
Measures and Procedures
After collecting the baseline information, the participant
completed the self-administered pre-intervention ques-
tionnaire. This questionnaire included questions about
participants’ demographic characteristics, whether they
had ever been screened for CRC, and whether or not they
preferred to get CRC screening in the future. It also
included the previously well-validated 16-item decisional
conflict scale which includes the following subscales:
informed, values clarity, support, uncertainty, and effec-
tive decision [35]. It also included self-reported health sta-
tus, using a single question [36]. We assessed knowledge
of colon cancer and CRC screening with a 15-item ques-
tionnaire drawn from previous questionnaires and our
Table 2 Statements Used in the Value Clarification Exercise
Construct For CRC Screening Against CRC Screening
Risk of Cancer It is important to me to get screened for colon cancer even though
the risk of getting colon cancer is small.
It is not important for me to get screened for colon
cancer because the risk of getting colon cancer is small.
Functional Status I understand that the prep and colonoscopy can be difficult but I
don’t think it would bother me that much.
I understand that the prep and colonoscopy can be
difficult and I think it would bother me.
Priority Based on my present condition, colon cancer screening is important
compared with other health concerns.
Based on my present condition, colon cancer screening
is not important compared with other health concerns.
Other Screening
Decisions
I like to prevent health problems before I have symptoms. I don’t like to look for health symptoms that aren’t
causing me problems.
Treatment I would want surgery if colon cancer was found even though it may
not extend my life.
I would not want surgery if colon cancer was found even
if there was a chance it could extend my life.
Worry Getting colon cancer screening would give me peace of mind. Getting colon cancer screening would not give me
peace of mind.
Knowing I Have
Cancer
I would want to know if I have cancer even if the cancer would not
cause me any problems.
I do not want to know if I have cancer if the cancer
would not cause me problems.
Complications
From Screening
I am willing to take the risk of having a complication in order to have
a chance to benefit from colon cancer screening.
I am not willing to take the risk of having a complication
in order to have a chance to benefit from colon cancer
screening.
Uncertainty It is important for me to be screened for colon cancer even though it
is uncertain whether or not it will prolong my life.
It is not important for me to be screened for colon
cancer because it is uncertain whether or not it will
prolong my life.
The table is divided into 3 columns. The first column lists the construct covered by each card. The second column displays a statement that is in favor of
screening. The third column displays a statement that is against tscreening
Figure 1 Risk of Dying from Colon Cancer Compared to Other
Common Diseases in the next 10 years. This figure shows how
colon cancer deaths compare to heart disease and stroke related
deaths. There were 6 versions of this figure available because the
decision aid was targeted to the participants’ age/gender. This
particular figure is for females age 80 and above. Each ◯
represented 1 person out of 1000 people in the figure.
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Page 5 of 13Figure 2 Risks of Having Serious Complications from Colonoscopy within the first 30 days. This figure shows information about the risks
for a complication within the first 30 days after a colonoscopy. Each ◯ represented 1 person out of 1000 people in the figure.
Figure 3 Balancing the Benefits and Risks of a Colonoscopy. Three different balance scales were shown to represent how CRC screening
may or may not be beneficial for someone in 3 states of health (good, fair or poor). The scales showed how benefits or risks could outweigh
each other or balance out depending on health state. A brief explanation for each scale was also provided underneath each picture.
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designed to determine basic knowledge about testing
options and the key messages important for older adults
presented in the decision aid. Upon completion of the
pre-questionnaire, the participants read the decision aid
booklet and participated in the values clarification exer-
cise with the RA described above. After this exercise they
completed a second, post-intervention questionnaire.
Outcomes for the Uncontrolled Trial
Our primary outcome was defined as the proportion of
patients who were prepared to make an individualized
decision of whether or not to undergo CRC screening.
This outcome was based on the informed decision mak-
ing model in which patients are adequately informed
about the risks and benefits of screening and have con-
sidered their personal values about the decision [26].
Mathieu and colleagues developed this combined mea-
sure using knowledge and clear values for mammogra-
phy screening in the elderly [20]. For our study, we
defined ap r i o r i67% (10/15 questions correct) as ade-
quate knowledge and clear values as 25 or less on values
clarity subscale of decisional conflict scale because this
cut point represents clear values. Secondary outcomes
included the individual’s knowledge and the clear values
subscale, overall score on the decisional conflict scale,
and whether or not they preferred to undergo screening.
We also compared the results of the card-sorting values
clarification exercise verbally with participants to deter-
mine agreement with their stated preference.
We performed exploratory analyses to test whether
our primary and secondary outcomes varied according
to some key co-variables that could have an effect on
either decision making outcomes or screening prefer-
ence, including literacy, health state, 4-year mortality
index, number of chronic conditions, previous CRC
screening, and demographic characteristics, such as age,
gender, race, education, and income.
Perceptions of the Decision Aid
In addition, we asked questions to determine partici-
pants’ perceptions of the decision aid and to identify
areas that may need to be revised. We asked them to
rate each of the six sections of the decision aid and the
values clarification exercise using a 4 point Likert scale
from poor to excellent. Finally, we asked about the
length, the amount of information and whether the
decision aid was useful.
Data analysis
First, we calculated frequencies for categorical data. To
test the differences in responses to questions before and
after the decision aid, we used McNemar’s test for cate-
gorical measures and paired t-tests for continuous mea-
sures. To assess associations between participant
characteristics and post-decision aid outcomes (knowl-
edge, clear values, prepared to make an informed
Figure 4 Percent Correct for Knowledge Questions Before and After Decision Aid. The percentage of correct answers on the 15-item
questionnaire given Pre Decision Aid and Post Decision Aid. Participants responded to the following True/False questions: 1. No direct evidence
supports screening. (T) 2. ACS recommends screening all adults. (F) 3. People in poor health are NOT likely to benefit. (T) 4. Longer a person lives
the more likely they are to benefit. (T) 5. Risk of dying from heart disease is greater than dying from CRC. (T) 6. People need to live at least 5
years to benefit from screening. (T) 7. CRC screening is a choice for people ≥ 75. (T) 8. Tests look for colon cancer before symptoms. (T) 9. FOBT
uses a lighted tube to check for CRC. (F) 10. CRC is the kind of cancer that grows quickly. (F) 11. Positive FOBT cards require a colonoscopy. (T)
12. During a colonoscopy polyps can be removed. (T) 13. Life expectancy is influenced by current health conditions. (T) 14. Not all people with
CRC will need surgery. (T) 15. Bleeding and perforations are NOT complications of colonoscopy. (F)
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square or Fisher’s exact tests for categorical data and
t-tests for continuous data.
Human Subjects
The study was approved by the Institutional Review
B o a r da tt h eU n i v e r s i t yo fN o r t hC a r o l i n aa tC h a p e l
Hill. Participants received $25 for their participation.
Results
We recruited a convenience sample of 49 participants
for the uncontrolled trial. Subsequently, one participant
was excluded because she failed the cognitive screener,
one was excluded because he reported a history of colon
cancer after finishing the study, and one was not able to
complete the literacy measure and was excluded.
Among the remaining 46, three were legally blind and
had the questions and decision aid read to them.
Because of their inability to see, they were not able to
participate in value clarification exercise. Our partici-
pants were primarily women (85%), most were white
(72%), and 59% had completed at least some college
(Table 3). Participants had a wide range of literacy
levels, self reported health status, 4 year risk of mortal-
ity, and number of co-morbidities. Over half (65%)
reported previous CRC screening.
Uncontrolled Trial Outcomes
Primary Outcome: Proportion prepared to make an
individualized decision
Our ap r i o r icriteria for classifying participants who
were prepared to make an individualized decision
included 1) adequate knowledge defined as 67% of the
true/false questions answered correctly (10 of 15 ques-
tions correct) and clear values defined as 25 or less on
values clarity subscale of decisional conflict scale. Using
these two thresholds, 4% were prepared to make an
individualized decision before the decision aid and after
using the decision aid, 41% fulfilled the criterion
(p < 0.01).
Secondary Outcomes
The decision aid increased overall knowledge of colon
cancer screening. At baseline 4% of the respondents
reached the threshold for adequate knowledge by
responding to 10 of the 15 true/false knowledge ques-
tions correctly. After exposure to the decision aid 52%
of the respondents reached this knowledge threshold
(p < 0.01). For five of the knowledge questions 70% or
more of respondents responded correctly to the ques-
tions at baseline: 1) The longer a person lives the more
likely they are to benefit; 2) Screening is a choice; 3)
CRC screening tests look for cancer before they have
symptoms; 4) During a colonoscopy polyps can be
removed; and 5) Life expectancy is influenced by current
health status (Figure 4). For these questions the increase
in the proportion of people answering correctly after the
decision aid was modest. For seven of the knowledge
questions the proportion of participants who responded
correctly increased by 25% or more after using the deci-
sion aid. These included the following constructs: 1) No
direct evidence supports screening for adults ages 75
and older; 2) ACS recommendations for elderly 3) Peo-
ple in poor health are not likely to benefit from colon
cancer screening 4) Risk of dying from heart disease is
Table 3 Participant Characteristics n = 46.
Mean age (range) 83 (75-95)
N (%)
Gender
Female 39 (85)
Race
White 33 (72)
Black 11 (24)
Other 2 (4)
Education
High school graduate or less 19 (41)
Some college or more 27 (59)
Previous CRC Screening 30 (65)
Literacy*
Adequate 28 (64)
Marginal 5 (11)
Inadequate 11 (25)
Number of co-morbidities
0-2 5 (11%)
3-7 27 (59%)
8+ 14 (30%)
Self Reported Health Status
Excellent/very good/good 20 (43%)
Good 17 (37%)
Fair/poor 9 (20%)
Four year mortality index
< 4% risk 5 (11)
15% risk 18 (39)
42% risk 17 (37)
64% risk 6 (13)
Forty-six people participated in the study but 3 individuals were unable to
complete the literacy assessment due to blindness
* N = 43, as 3 could not complete literacy assessment due to blindness
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live five years to benefit from screening 6) Growth rate
of CRC 7) Positive FOBT cards require colonoscopy.
The proportion of respondents having clear values
increased after viewing the decision aid, but the change
was not statistically significant. (28 of 46 (61%) before
vs. 32 of 46 (70%) after), Ten participants changed their
clear value categories, 7 were unclear before the using
the decision aid and became clear after using it while 3
were clear before the decision aid and unclear after its
use (p = 0.27). Evaluating the full decisional conflict
scale demonstrated a decrease in decisional conflict
score after using the decision aid (mean score 34 vs 28
p < 0.01).
Screening Preference
When we asked participants prior to the decision aid, 31
(67%), participants indicated that they preferred to
undergo screening and after the using the decision aid
28 (61%) preferred to do so. Seven participants (15%)
changed their screening intent after using the decision
aid, with 5 deciding against screening after the decision
aid and 2 changing in favor of screening. (p = 0.76).
Values Clarification Exercise
Among the 43 participants who completed the values
clarification exercise, 13 had negative scores when the 9
cards were summed, indicating that the majority of
cards they chose were against screening (Figure 5). The
remaining 30 participants had positive scores when their
cards were summed. When we compared participants’
screening preference to the results of the values clarifi-
cation exercise, we found that all 23 participants with
scores on the card-sorting exercise of +5 or greater pre-
ferred screening. All 8 with scores of -3 or lower pre-
ferred to not have screening. In the middle range of
scores from -1 to +3, 3 were in favor of screening and 9
preferred not to be screened. When asked at the end of
the values clarification exercise, 32 (74%) of 43 partici-
pants agreed that their score represented their current
preference for screening.
Participants’ Characteristics Associated with Outcomes
When we explored associations between participant
characteristics and our primary and secondary out-
comes, we found some potentially important associa-
tions despite the small numbers (Table 4). After using
the decision aid, those less than age 83 were more likely
to be prepared to make an individualized decision than
those age 83 or older (59% vs 25% p = 0.02). Partici-
pants who had previously undergone CRC screening
were more likely to have clear values (80% vs 50% p =
0.03) and prefer to be screened (73% vs 38% p = 0.02)
Participants with adequate literacy were more likely to
have adequate post-decision aid knowledge than those
with inadequate or marginal literacy (64% vs 31%
p=0 . 0 4 )a n dw e r em o r el i k e l yt ob ep r e p a r e dt om a k e
an individualized decision after decision aid use: (54% of
those with adequate literacy met the criteria, vs. 19% of
those with inadequate or marginal literacy p = 0.03)
Similarly, those with excellent to very good self-reported
health status were more likely to have adequate knowl-
edge and to be prepared to make an individualized
decision compared to those with good to poor health
(70% vs 38% p = 0.034 and 65% vs 23% p = 0. 004
respectively). As 4 year mortality increased, participants
were less like to reach the threshold for clear values
(p < 0.01) or preparation for an individualized decision
making (p = 0.02) and were less likely to intend to
undergo screening (p = 0.04).
Participants’ Perceptions of the Decision Aid
Forty-one (89%) of the participants reported that the
decision aid was useful. All six of the sections of the
decision aid and the values clarification exercise were
highly rated with 38 to 43 of the participants ranking
each of the sections good to excellent. Thirty-seven par-
ticipants (81%) thought the amount of information was
just right while 5 participants (11%) thought that there
was too little information.
Discussion
During the development phase of the decision aid, we
found that participants understood the key messages,
thought the information was important, and did not
find the information offensive. During the testing phase,
participants reported that the decision aid was useful
and rated the each of the sections highly. The results of
our uncontrolled trial demonstrated that participants
were better prepared to make an individualized decision,
our primary outcome, after using the decision aid than
before its use. The improvement was due primarily to
an improvement in knowledge scores after decision aid
use, as little change in the value sub-scale of the decisio-
nal conflict scale was noted. Participants also had a
decrease in overall decisional conflict after using the
decision aid. Our exploratory analyses reveal some areas
of future study. Specifically, participants with inadequate
or marginal literacy did not demonstrate as great an
improvement in knowledge than those with higher lit-
eracy. Similarly, those in poorer health state (either by
self report or the 4 year mortality index) appeared to
have less clear values about screening than those in bet-
ter health.
Previous studies have evaluated educational materials
about cancer screening in older adults. Wolf and collea-
gues found that older adults were able to comprehend
information about the efficacy of CRC for people of all
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ences in potential benefits due to advanced age or
health state were not provided [23]. Resnick found that
when older adults where encouraged to consider not
only the advantages but also the disadvantages of health
promotion activities like CRC screening, they may be
less willing to undergo screening [24]. However, partici-
pants’ understanding of the information was not for-
mally evaluated, so it is unclear whether understanding
the risks and benefits changed their screening intent.
In this study, we developed a decision aid which was
composed of both an educational component and a
values clarification exercise consistent with international
standards of decision aid development [29]. Importantly,
the information in the decision aid was targeted to par-
ticipants’ age and gender. Targeting is important for this
decision because the likelihood of benefiting from
screening depends on an individual’s risk of competing
causes of mortality which varies by age and gender.
Developing effective interventions to promote indivi-
dualized decision making about cancer screening in the
elderly is important to improve their decision making.
Available data suggests suboptimal decision making is
ongoing, despite expert groups’ recommendations for
individualized decisions in this age group. Recent data
from the V.A. demonstrates that screening test comple-
tion among the healthiest veterans age 70 and older was
similar to those in the poorest health; 47% compared to
41% respectively [11]. This could lead to net harm in
those who are unlikely to benefit, as they are exposed to
the risks of screening without the potential to benefit.
Furthermore, those who could benefit from screening
may not get the opportunity to complete screening tests
if they are not offered screening tests because of their
advanced age.
Interventions, such our decision aid, that target older
adults and inform them about the risks and the benefits
of CRC screening relevant to their situation and have
individuals consider their personal preferences have the
potential to improve the decision making process in
clinical practice. This study is the first step to test this
hypothesis. In this uncontrolled trial, improvement in
knowledge of key facts needed to make an informed yet
individualized decision about CRC in older adults was
encouraging. However, the decision aid will need to be
revised to more effectively reach inadequate and mar-
ginal literacy users as well as those in poorer health
states.
Figure 5 Values Clarification Exercise Score and CRC Screening Preference. Values clarification scores were summed according to cards the
participant chose. Scores could range from -9 to 9. Those with negative scores indicated a preference against screening while those with
postive scores indicated a preference for screening. We compared each participant’s stated screening preference with their values score.
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Participant
Characteristics
Percent Reaching
Knowledge Threshold
Percent Reaching Clear
Value Threshold
Percent Prepared to Make an
Individualized Decision
Percent Reporting a
Preference to be Screened
Age
< 83 (n = 22) 64% 73% 59% 73%
≥ 83 (n = 24) 42% 67% 25% 50%
Sex
Women (n = 39) 49% 67% 38% 59%
Men (n = 7) 71% 86% 57% 71%
Race
White (n = 34) 59% 74% 47% 56%
African-American (n =
11)
36% 55% 27% 73%
Other (n = 1) 0% 100% - 100%
Education
High School graduate
or less (n = 19)
47% 63% 32% 58%
Some College or more
(n = 27)
56% 74% 48% 63%
Previous CRC
screening
Yes (n = 30) 57% 80% 50% 73%
No (n = 16) 44% 50% * 25% 38%*
Literacy
Adequate (n = 28) 64% 79% 54% 54%
Marginal/Inadequate
(n = 16)
31%* 56% 19%† 69%
Self-reported health
status
excellent/very good (n
= 20)
70% 90% 65% 70%
good/fair/poor (n =
26)
38% * 54% † 23%† 54%
Co-morbidities
0-2 (n = 5) 80% 60% 60% 40%
3-7 (n = 27) 59% 74% 48% 70%
8 or more (n = 14) 29% 64% 21% 50%
4 year mortality
index
< 4% (n = 5) 80% 100% 80% 100%
15% (n = 18) 61% 89% 56% 61%
42% (n = 17) 41% 59% 29% 65%
64% (n = 6) 33% 17%† 0% † 16% †
The table looks at the associations between participant characteristics and outcomes after decision aid use
*statistically significant at < 0.05 using Chi-square
†statistically significant at < 0.05 using Fisher’s exact
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reached the threshold for clear values before the deci-
sion aid with a 9% increase after using the decision aid.
There are several potential reasons for this small
change. First, the decision aid could have had little effect
on helping participants clarify their values. Another pos-
sibility is that the participants were already clear about
which course to take. A randomized controlled trial of a
decision aid for breast cancer screening in women age
70 and older also had a high proportion of participants
(> 80%) with clear values in both the intervention and
control arms [20]. More than 80% in both groups
reported that they would continue screening, suggesting
perhaps that this population was clear that they wanted
to continue screening. However, the investigators did
not assess whether screening intent varied with health
state or increasing age. Although the numbers are small,
our data suggest that those who have shorter life expec-
tancies, estimated by the 4 year mortality index, have
less clear values. Being informed about the decreased
benefit and increased risks of screening with increasing
age could have created some cognitive dissonance about
what they believe about CRC screening. In our future
w o r k ,w ep l a nt oa d d r e s st h i sq u e s t i o ni nal a r g e r
sample.
The uncontrolled trial was designed as a pilot test of
the decision aid we developed. Obviously, further testing
is needed before definitive conclusions can be made.
There are several limitations that deserve consideration
in addition to those already mentioned. Although we
used formative work to develop the content of the edu-
cational material and the values clarification exercise,
additional information may be important to older adults
making decisions about CRC screening that we have not
captured. The study was limited by its uncontrolled
design. The differences we saw could theoretically be
due to temporal trends, but the time between the pre
and post surveys was short, so we think this is unlikely.
It is also possible that participants could have answered
the follow up questions in socially desirable ways. This
seems unlikely for the knowledge questions but could
b ep o s s i b l ef o rt h ev a l u e ss u b s c a l eq u e s t i o n s .O nt h e
other hand, we demonstrated that we were able to
recruit participants with advanced age and a wide distri-
bution of health states, which will be key in future stu-
dies. This task can be challenging because often elderly
patients who have numerous co-morbidities often opt
out of participating in research studies. Finally, we
explored potentially important associations between par-
ticipant characteristics and outcomes. In doing so, we
performed multiple comparisons; therefore, caution
should be used in interpreting these preliminary results
as some of the associations we found could have
occurred by chance. Additional research is needed assess
these associations with larger samples.
Conclusions
In summary, we found that the targeted decision aid
designed to assist the elderly in deciding whether or not
to undergo colorectal cancer screening was acceptable
and useful to participants. In an uncontrolled trial, the
participants appeared better prepared to make an indivi-
dualized decision about screening. Additional research is
needed to determine whether the targeted decision aid
would be useful in a clinical setting to prepare patients
for discussions with medical providers.
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